Transitional Type 1 and 2 B Lymphocyte Subsets Are Differentially Responsive to Antigen Receptor Signaling*

Overview of attention for article published in Journal of Biological Chemistry, September 2002

Altmetric Badge

Mentioned by

patent: 4 patents

wikipedia: 4 Wikipedia pages

Readers on

mendeley: 92 Mendeley

So far, Altmetric has seen 4 patents that reference this research output.

CLOZAPINE FOR USE IN TREATING PATHOGENIC IMMUNOGLOBULIN DRIVEN B CELL DISEASE

Application WO-2021019249-A1

World Intellectual Property Organisation (WIPO)

CLOZAPINE FOR THE TREATMENT OF A IMMUNOGLOBULIN DRIVEN B CELL DISEASE

Application WO-2019149862-A1

World Intellectual Property Organisation (WIPO)

NOVEL USES

Application WO-2019149861-A1

World Intellectual Property Organisation (WIPO)

CLOZAPINE FOR THE TREATMENT OF IG-E DRIVEN B CELL DISEASES

Application WO-2019149863-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.